Search results
Why CymaBay, With 159% Growth This Year, Just Surged For A Second Day Running
Investor's Business Daily· 8 months agoShares of CBAY stock surged for a second day Friday as analysts compared CymaBay Therapeutics'...
Biotech Stock Roundup: BIIB's Q4 Results, CBAY Up on GILD's Acquisition & Other Updates
Zacks via Yahoo Finance· 2 months agoIt has been a busy week for the biotech sector, with earnings results. Biogen BIIB reported...
Why CymaBay Therapeutics Stock Triumphed Again on Tuesday
Motley Fool· 8 months agoThe hot-streak biotech stock of the moment, CymaBay Therapeutics (NASDAQ: CBAY), again rose in price...
Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today
Motley Fool· 6 months agoHardly for the first time this year, biotech CymaBay Therapeutics (NASDAQ: CBAY) had a winning day...
The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and...
Zacks via Yahoo Finance· 2 months agoFor Immediate Release Chicago, IL – February 23, 2024 – Zacks.com announces the list of stocks...
Why CymaBay Therapeutics Stock Nose-Dived This Week
Motley Fool· 11 months agoA significant miss on quarterly earnings combined with a big change in its C-suite put a damper on CymaBay Therapeutics (NASDAQ: CBAY) stock this week....
Why CymaBay Therapeutics Stock Is Jumping Today
Motley Fool· 8 months agoThe continued momentum is a result of CymaBay's announcement yesterday of positive top-line results from a late-stage clinical study evaluating...
Company News for Feb 13, 2024
Zacks via Yahoo Finance· 2 months agoDiamondback Energy, Inc. (FANG) shares jumped 9.4% after the company made an announcement of its merger agreement with Endeavor Energy Resources valued...